We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health is well-positioned to maintain its relevance and continue thriving in this competitive landscape. This text provides general information. Statista assumes no liability for the ...

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective ...

CVS Health appointed David Joyner president and CEO, effective Oct. 17, replacing Karen Lynch, who stepped down from the position. Mr. Joyner most recently served as executive vice president of ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured ...

R.I. — CVS Health will exit its core infusion services business in the coming months and plans to either close or sell 29 related pharmacies. The company stopped taking new patients seeking ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

Cantor Fitzgerald analyst Sarah James maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around. Joyner was previously the president of CVS Caremark, ...